Option Care Health, Inc. (NASDAQ:OPCH) Shares Acquired by Natixis Advisors LLC

Natixis Advisors LLC lifted its position in Option Care Health, Inc. (NASDAQ:OPCH) by 9.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 88,751 shares of the company’s stock after purchasing an additional 7,529 shares during the quarter. Natixis Advisors LLC owned approximately 0.05% of Option Care Health worth $2,778,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. increased its stake in Option Care Health by 317.9% in the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after purchasing an additional 73,312 shares during the period. Comerica Bank increased its position in Option Care Health by 6.5% in the 1st quarter. Comerica Bank now owns 760,915 shares of the company’s stock valued at $25,521,000 after acquiring an additional 46,639 shares during the period. Janus Henderson Group PLC raised its stake in Option Care Health by 182.9% during the 1st quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after acquiring an additional 146,837 shares during the last quarter. Victory Capital Management Inc. lifted its position in Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after acquiring an additional 1,585,818 shares during the period. Finally, Edgestream Partners L.P. grew its stake in shares of Option Care Health by 96.8% in the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock valued at $9,736,000 after purchasing an additional 172,845 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $23.13 on Monday. The firm has a market capitalization of $3.94 billion, a price-to-earnings ratio of 19.44, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The business’s 50 day simple moving average is $27.62 and its 200-day simple moving average is $29.09. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on OPCH shares. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price objective for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Truist Financial dropped their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Barrington Research reduced their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Finally, The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $30.83.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.